Kuano is a next-generation biotech company applying quantum mechanics and artificial intelligence to structure-based drug discovery. Its proprietary platform models enzyme dynamics and transition states at quantum resolution, enabling the rational design of highly selective small molecules, including covalent binders. Kuano operates a flexible service and partnership model, supporting pharma and biotech partners while advancing its own internal pipeline through early-stage discovery and deal generation.